1. Home
  2. GDTC vs BGI Comparison

GDTC vs BGI Comparison

Compare GDTC & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • BGI
  • Stock Information
  • Founded
  • GDTC 2018
  • BGI 1879
  • Country
  • GDTC Singapore
  • BGI Canada
  • Employees
  • GDTC N/A
  • BGI N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • BGI
  • Sector
  • GDTC Health Care
  • BGI
  • Exchange
  • GDTC Nasdaq
  • BGI Nasdaq
  • Market Cap
  • GDTC 24.8M
  • BGI 22.7M
  • IPO Year
  • GDTC 2023
  • BGI 2005
  • Fundamental
  • Price
  • GDTC $1.95
  • BGI $1.10
  • Analyst Decision
  • GDTC
  • BGI
  • Analyst Count
  • GDTC 0
  • BGI 0
  • Target Price
  • GDTC N/A
  • BGI N/A
  • AVG Volume (30 Days)
  • GDTC 268.9K
  • BGI 53.1K
  • Earning Date
  • GDTC 01-01-0001
  • BGI 11-26-2025
  • Dividend Yield
  • GDTC N/A
  • BGI N/A
  • EPS Growth
  • GDTC N/A
  • BGI N/A
  • EPS
  • GDTC N/A
  • BGI N/A
  • Revenue
  • GDTC $573,193.00
  • BGI $124,446,731.00
  • Revenue This Year
  • GDTC $5.37
  • BGI N/A
  • Revenue Next Year
  • GDTC N/A
  • BGI N/A
  • P/E Ratio
  • GDTC N/A
  • BGI N/A
  • Revenue Growth
  • GDTC 63.03
  • BGI N/A
  • 52 Week Low
  • GDTC $1.65
  • BGI $0.56
  • 52 Week High
  • GDTC $4.05
  • BGI $2.20
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 42.90
  • BGI 46.13
  • Support Level
  • GDTC $1.68
  • BGI $1.13
  • Resistance Level
  • GDTC $3.10
  • BGI $1.14
  • Average True Range (ATR)
  • GDTC 0.34
  • BGI 0.05
  • MACD
  • GDTC -0.06
  • BGI -0.02
  • Stochastic Oscillator
  • GDTC 14.96
  • BGI 12.50

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

Share on Social Networks: